Trombo ASS enteric coated tablets 75 mg. №30


Manufacturer: Austria



To reduce the risk of: death in patients with suspected acute myocardial infarction; fatalities in patients with myocardial infarction; transient ischemic attack (TIA) and stroke in patients with TIA; morbidity and fatal consequences with stable and unstable angina. For the prevention of: thrombosis and embolism after surgery on the vessels (percutaneous transluminal catheter angioplasty (RTSA), carotid artery endarterectomy, coronary artery bypass grafting (CABG), arteriovenous bypass); deep vein thrombosis and pulmonary embolism after long-term immobilization (after surgery); myocardial infarction in patients at high risk for cardiovascular complications (diabetes mellitus, controlled arterial hypertension) and individuals with multifactorial risk for cardiovascular disease (hyperlipidemia, obesity, smoking, old age). For secondary prevention of stroke.